Latest Publications

Share:

Supreme Court Issues Decision in AMP v. Myriad -- Association for Molecular Pathology v. Myriad Genetics, Inc. (2013)

In a much anticipated decision, the Supreme Court issued its opinion this morning in Association for Molecular Pathology v. Myriad Genetics, Inc. In an opinion by Justice Thomas, joined by Chief Justice Roberts, Justices...more

6/14/2013 - AMP v Myriad Biotechnology DNA Human Genes Myriad Patent-Eligible Subject Matter Patents SCOTUS

USPTO Issues Memo on AMP v. Myriad to Examining Corps

On the same day that the Supreme Court handed down its decision in Association for Molecular Pathology v. Myriad Genetics, Inc., the U.S. Patent and Trademark Office issued a one-page memorandum to its Patent Examining Corps...more

6/14/2013 - AMP v Myriad DNA Human Genes Myriad Patent-Eligible Subject Matter Patents SCOTUS USPTO

Congress Continues Efforts to "Reform" U.S. Patent Law

It has been less than three months since the remaining provisions of the Leahy-Smith America Invents Act (AIA) took effect, and just short of five months since the AIA Technical Corrections Act was enacted to "correct and...more

6/11/2013 - America Invents Act Infringement Patent Reform Patent Trolls Patents Proposed Legislation USPTO

SIPO and KIPO to Use Cooperative Patent Classification System

Earlier this year, the U.S. Patent and Trademark Office and European Patent Office announced the formal launch of the Cooperative Patent Classification (CPC) system, a global classification system for patent documents. The...more

6/10/2013 - Coopertive Patent Classification System Patents USPTO WIPO

USPTO Proposes Rules Changes to Implement Patent Law Treaty

In April, the U.S. Patent and Trademark Office published a notice in the Federal Register (78 Fed. Reg. 21788) proposing changes to the rules of practice for consistency with the Patent Law Treaty (PLT) and title II of the...more

6/6/2013 - Patent Applications Patent Cooperation Treaties Patent Law Treaty Patents PLTIA USPTO

USPTO News Briefs -- May 28, 2013

USPTO Modifies After Final Consideration Pilot Program - Earlier this month, the U.S. Patent and Trademark Office published a notice in the Federal Register (78 Fed. Reg. 29117) regarding modifications to the After...more

5/29/2013 - AFCP Patent Applications Patents Patents for Humanity Program USPTO

WIPO Reports Increase in International Application Filings in 2012

In March, the World Intellectual Property Organization (WIPO) announced that International patent applications filed under the Patent Cooperation Treaty (PCT) increased by 6.6% in 2012. WIPO noted that of the 194,000 PCT...more

5/17/2013 - Patent Applications WIPO

Bowman v. Monsanto Co. (2013)

Today, in Bowman v. Monsanto Co., the Supreme Court determined that the doctrine of patent exhaustion did not permit a farmer who buys patented seeds to repro­duce them through planting and harvesting without the patent...more

5/14/2013 - Bowman v Monsanto Genetically Engineered Seed Infringement Monsanto Patent Exhaustion Patents SCOTUS Seeds

MBHB Snippets: Review of Developments in Intellectual Property Law - Spring 2013 - Volume 11, Issue 2: Comments on New AIA Rules

On March 16, 2013, the final (and most significant) portion of the Leahy-Smith America Invents Act (AIA) took effect, and the United States broke from a first-to-invent regime to a first-inventor-to-file (FITF) regime. Of...more

5/14/2013 - America Invents Act First-to-File First-to-Invent Patent Applications Patents

MBHB Snippets: Review of Developments in Intellectual Property Law - Spring 2013 - Volume 11, Issue 2

In This Issue: Comments on New AIA Rules; Implementing the New Micro Entity Status at the U.S. Patent Office; Obama Administration Focuses on Chinese Trade Secret Misappropriation; and Tiffany & Co. v. Costco Wholesale...more

5/13/2013 - America Invents Act China Costco Fees First-to-File Generic Inventors Micro Entity Status Misappropriation Patents Tiffany and Company Trade Secrets Trademarks USPTO

Senators Back 12-Year Data Exclusivity Period for Biosimilars and President Obama (Once Again) Does Not

On March 22, Senators Max Baucus (D-MT) and Orrin Hatch (R-UT), the Chairman and Ranking Member, respectively, of the Senate Committee on Finance, sent a letter to Ambassador Demetrios Marantis, the Acting United States Trade...more

5/10/2013 - Affordable Care Act Barack Obama Biologics Price Competition and Innovation Act of 2009 Biosimilars Prescription Drugs

Inovia Releases 2013 Report on Global Patent Trends

Patent services provider inovia announced the release of its 2013 report on global patent and IP trends today. In compiling the report, inovia, which produces products for PCT national phase entry, European patent...more

5/9/2013 - EPO EU Filing Requirements JPO KIPO Patent Applications Patents USPTO

Rubin v. General Hospital Corp. (Fed. Cir. 2013)

On March 28, the Federal Circuit in Rubin v. General Hospital Corp. affirmed judgment by the District Court for the District of Massachusetts dismissing the suit brought by Drs. Berish Rubin and Sylvia Anderson against The...more

5/8/2013 - Biotechnology Human Genes Inventors Patents

Dawson v. Dawson (Fed. Cir. 2013)

On March 25, the Federal Circuit in Dawson v. Dawson affirmed a determination by the Board of Patent Appeals and Interferences that the University of California, San Francisco (UCSF) failed to establish sole conception by Dr....more

5/7/2013 - Inventors Patent Applications Patents World Health Organization

Biotech Venture Funding Down 33% in First Quarter

Earlier this month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the first quarter of...more

5/1/2013 - Biotechnology Venture Capital Venture Funding

Biogen Idec, Inc. v. GlaxoSmithKline LLC (Fed. Cir. 2013)

Yesterday, in Biogen Idec, Inc. v. GlaxoSmithKline LLC, the Federal Circuit affirmed the determination by the District Court for the Southern District of California that the claim term "anti-CD20 antibody" as used in U.S....more

4/18/2013 - Biogen Idec GlaxoSmithKline Patents

A Primer on Claim Construction -- Comments on Dr. Mason's Response

Yesterday, we posted a response from Dr. Chris Mason of Cornell University to a recent Patent Docs post and an article posted by Dr. Chris Holman on Holman's Biotech IP Blog. Dr. Mason co-authored an article in the current...more

4/12/2013 - Claim Construction DNA Gene Patenting Human Genes Patents

White House Unveils BRAIN Initiative

Last week, President Obama announced a new research initiative designed to advance our understanding of the human brain. It is hoped that the new initiative, dubbed the BRAIN (Brain Research through Advancing Innovative...more

4/10/2013 - Barack Obama BRAIN Initiative Medical Research Research Funding

Revisiting Genome Medicine Article on "Pervasive Sequence Patents" That "Cover the Entire Human Genome"

Last week, we reported on an article in the current issue of Genome Medicine which contends that due to the non-specificity of sequence uniqueness across the genome and the broad scope of claims to nucleotide sequences, the...more

4/9/2013 - DNA Gene Patenting Genome Project Patents

USPTO Issues Rules to Implement AIA Technical Corrections

In the past week, the U.S. Patent and Trademark Office has published two Federal Register notices to implement technical corrections to the Leahy-Smith America Invents Act. On Monday, the Office issued an interim final rule...more

4/4/2013 - Amended Legislation Patent Term Adjustment Patents USPTO

Genome Medicine Article Calls for Limits on Patenting of Existing Nucleotide Sequences

In an article published in the current issue of Genome Medicine, Jeffrey Rosenfeld of the University of Medicine & Dentistry of New Jersey and Christopher Mason of Cornell University contend that due to the non-specificity of...more

4/3/2013 - DNA Human Genes Myriad Patent-Eligible Subject Matter Patents

GEN Compiles List of Top Biopharma R&D Spenders

Earlier this month, Genetic Engineering & Biotechnology News published its list of the top 20 best-selling prescription drugs worldwide for 2012 (see "GEN Compiles List of Top Selling Drugs for 2012"). The biotech...more

3/21/2013 - Biopharmaceutical Biotechnology Patents Pharmaceutical Prescription Drugs Research Funding

IPO Files Amicus Brief in Support of Respondents in AMP v. Myriad Genetics

In an amicus brief filed last week in support of respondents Myriad Genetics, Inc. et al., the Intellectual Property Owners Association (IPO) asked the Supreme Court to affirm the Federal Circuit's decision in Association for...more

3/20/2013 - AMP v Myriad Human Genes Intellectual Property Owners Association Patent-Eligible Subject Matter Patents SCOTUS

USPTO News Briefs - March 18, 2013

USPTO Extends Comment Period on Notice Regarding Preparation of Patent Applications - In January, the U.S. Patent and Trademark Office published a notice in the Federal Register (78 Fed. Reg. 2960) requesting public...more

3/19/2013 - Patent Applications Patent Examinations Patent Prosecution Highway Patents SIPO USPTO

GEN Compiles List of Top Selling Drugs for 2012

Genetic Engineering & Biotechnology News has compiled a list of the top 20 best-selling prescription drugs worldwide for 2012. GEN's list, which the journal released on March 5 (see "Top 20 Best-Selling Drugs of 2012"), was...more

3/13/2013 - Pharmaceutical Prescription Drugs Sales

×

Expand Your Reach

JD Supra gets your content noticed, increases your visibility and makes your marketing efforts hassle free...

Learn More  or  Schedule a demo